vs
FIRST BANCORP（FBP）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
FIRST BANCORP的季度营收约是Ultragenyx Pharmaceutical Inc.的1.2倍（$257.2M vs $207.3M），FIRST BANCORP净利率更高（33.9% vs -62.0%，领先95.9%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 6.5%），FIRST BANCORP自由现金流更多（$103.2M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 5.6%）
第一中西部银行总部位于美国伊利诺伊州芝加哥市，地处奥黑尔机场东侧，其前身可追溯至伊利诺伊州乔利埃特市。发展至今，该行服务范围覆盖芝加哥众多郊区，包括印第安纳州西北部、伊利诺伊州南部、威斯康星州东南部以及含爱荷华州在内的四城地区，是美国规模最大的银行机构之一。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
FBP vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $257.2M | $207.3M |
| 净利润 | $87.1M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | 41.7% | -54.7% |
| 净利率 | 33.9% | -62.0% |
| 营收同比 | 6.5% | 25.9% |
| 净利润同比 | 15.1% | 3.5% |
| 每股收益（稀释后） | $0.55 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $257.2M | $207.3M | ||
| Q3 25 | $248.7M | $159.9M | ||
| Q2 25 | $246.8M | $166.5M | ||
| Q1 25 | $248.1M | $139.3M | ||
| Q4 24 | $241.5M | $164.6M | ||
| Q3 24 | $234.6M | $139.5M | ||
| Q2 24 | $231.7M | $147.0M | ||
| Q1 24 | $230.5M | $108.8M |
| Q4 25 | $87.1M | $-128.6M | ||
| Q3 25 | $100.5M | $-180.4M | ||
| Q2 25 | $80.2M | $-115.0M | ||
| Q1 25 | $77.1M | $-151.1M | ||
| Q4 24 | $75.7M | $-133.2M | ||
| Q3 24 | $73.7M | $-133.5M | ||
| Q2 24 | $75.8M | $-131.6M | ||
| Q1 24 | $73.5M | $-170.7M |
| Q4 25 | 41.7% | -54.7% | ||
| Q3 25 | 42.7% | -106.9% | ||
| Q2 25 | 41.7% | -64.8% | ||
| Q1 25 | 40.4% | -102.6% | ||
| Q4 24 | 39.8% | -74.3% | ||
| Q3 24 | 41.1% | -94.6% | ||
| Q2 24 | 43.8% | -79.1% | ||
| Q1 24 | 42.3% | -151.9% |
| Q4 25 | 33.9% | -62.0% | ||
| Q3 25 | 40.4% | -112.8% | ||
| Q2 25 | 32.5% | -69.0% | ||
| Q1 25 | 31.1% | -108.5% | ||
| Q4 24 | 31.4% | -80.9% | ||
| Q3 24 | 31.4% | -95.7% | ||
| Q2 24 | 32.7% | -89.5% | ||
| Q1 24 | 31.9% | -156.8% |
| Q4 25 | $0.55 | $-1.28 | ||
| Q3 25 | $0.63 | $-1.81 | ||
| Q2 25 | $0.50 | $-1.17 | ||
| Q1 25 | $0.47 | $-1.57 | ||
| Q4 24 | $0.46 | $-1.34 | ||
| Q3 24 | $0.45 | $-1.40 | ||
| Q2 24 | $0.46 | $-1.52 | ||
| Q1 24 | $0.44 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $421.0M |
| 总债务越低越好 | $290.0M | — |
| 股东权益账面价值 | $2.0B | $-80.0M |
| 总资产 | $19.1B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.15× | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $421.0M | ||
| Q3 25 | — | $202.5M | ||
| Q2 25 | — | $176.3M | ||
| Q1 25 | — | $127.1M | ||
| Q4 24 | — | $174.0M | ||
| Q3 24 | — | $150.6M | ||
| Q2 24 | — | $480.7M | ||
| Q1 24 | — | $112.3M |
| Q4 25 | $290.0M | — | ||
| Q3 25 | $290.0M | — | ||
| Q2 25 | $320.0M | — | ||
| Q1 25 | $331.1M | — | ||
| Q4 24 | $561.7M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $2.0B | $-80.0M | ||
| Q3 25 | $1.9B | $9.2M | ||
| Q2 25 | $1.8B | $151.3M | ||
| Q1 25 | $1.8B | $144.2M | ||
| Q4 24 | $1.7B | $255.0M | ||
| Q3 24 | $1.7B | $346.8M | ||
| Q2 24 | $1.5B | $432.4M | ||
| Q1 24 | $1.5B | $140.3M |
| Q4 25 | $19.1B | $1.5B | ||
| Q3 25 | $19.3B | $1.2B | ||
| Q2 25 | $18.9B | $1.3B | ||
| Q1 25 | $19.1B | $1.3B | ||
| Q4 24 | $19.3B | $1.5B | ||
| Q3 24 | $18.9B | $1.5B | ||
| Q2 24 | $18.9B | $1.6B | ||
| Q1 24 | $18.9B | $1.3B |
| Q4 25 | 0.15× | — | ||
| Q3 25 | 0.15× | — | ||
| Q2 25 | 0.17× | — | ||
| Q1 25 | 0.19× | — | ||
| Q4 24 | 0.34× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $107.3M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $103.2M | $-100.8M |
| 自由现金流率自由现金流/营收 | 40.1% | -48.6% |
| 资本支出强度资本支出/营收 | 1.6% | 0.5% |
| 现金转化率经营现金流/净利润 | 1.23× | — |
| 过去12个月自由现金流最近4个季度 | $437.5M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $107.3M | $-99.8M | ||
| Q3 25 | $137.6M | $-91.4M | ||
| Q2 25 | $95.4M | $-108.3M | ||
| Q1 25 | $108.2M | $-166.5M | ||
| Q4 24 | $96.8M | $-79.3M | ||
| Q3 24 | $118.0M | $-67.0M | ||
| Q2 24 | $71.1M | $-77.0M | ||
| Q1 24 | $118.2M | $-190.7M |
| Q4 25 | $103.2M | $-100.8M | ||
| Q3 25 | $134.8M | $-92.7M | ||
| Q2 25 | $92.8M | $-110.7M | ||
| Q1 25 | $106.7M | $-167.8M | ||
| Q4 24 | $95.2M | $-79.5M | ||
| Q3 24 | $115.4M | $-68.6M | ||
| Q2 24 | $69.4M | $-79.0M | ||
| Q1 24 | $114.1M | $-193.9M |
| Q4 25 | 40.1% | -48.6% | ||
| Q3 25 | 54.2% | -58.0% | ||
| Q2 25 | 37.6% | -66.5% | ||
| Q1 25 | 43.0% | -120.5% | ||
| Q4 24 | 39.4% | -48.3% | ||
| Q3 24 | 49.2% | -49.2% | ||
| Q2 24 | 30.0% | -53.7% | ||
| Q1 24 | 49.5% | -178.2% |
| Q4 25 | 1.6% | 0.5% | ||
| Q3 25 | 1.2% | 0.8% | ||
| Q2 25 | 1.1% | 1.5% | ||
| Q1 25 | 0.6% | 1.0% | ||
| Q4 24 | 0.7% | 0.1% | ||
| Q3 24 | 1.1% | 1.2% | ||
| Q2 24 | 0.7% | 1.4% | ||
| Q1 24 | 1.8% | 3.0% |
| Q4 25 | 1.23× | — | ||
| Q3 25 | 1.37× | — | ||
| Q2 25 | 1.19× | — | ||
| Q1 25 | 1.40× | — | ||
| Q4 24 | 1.28× | — | ||
| Q3 24 | 1.60× | — | ||
| Q2 24 | 0.94× | — | ||
| Q1 24 | 1.61× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FBP
| Consumer Retail Banking Segment | $171.5M | 67% |
| Commercial And Corporate Segment | $46.9M | 18% |
| Mortgage Banking Segment | $22.4M | 9% |
| Virgin Islands Operations Segment | $18.6M | 7% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
